Long-term efficacy of dose intensified interferon-α 2b and ribavirin therapy for hepatitis C in HIV-coinfected patients

被引：0
|
作者：
Mannah, M [1 ]
Rockstroh, JK [1 ]
Gölz, J [1 ]
Klausen, G [1 ]
Dupke, S [1 ]
Stein, L [1 ]
Notheis, G [1 ]
Stoehr, A [1 ]
Mauss, S [1 ]
机构：
[1] Univ Bonn, Neurol Klin, D-53105 Bonn, Germany
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W901
引用
收藏
页码：A528 / A528
页数：1
相关论文
共 50 条
  • [1] Chronic hepatitis C in HIV-coinfected patients:: Feasibility and efficacy of interferon-α2b and ribavirin combination therapy
    Nasti, G
    di Gennaro, G
    Rizzardini, G
    Cadorin, L
    Tirelli, U
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) : 299 - 300
  • [2] Interferon-α and ribavirin combination therapy for hepatitis C in HIV-coinfected patients
    Rockstroh, JK
    Klausen, G
    Gölz, J
    Dupke, S
    Stein, L
    Notheis, G
    Stoehr, A
    Pascucci, GR
    Wasmuth, JC
    Mauss, S
    AIDS, 2000, 14 : S123 - S123
  • [3] Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
    Voigt, Esther
    Schulz, Christian
    Klausen, Gerd
    Goelz, Joerg
    Mauss, Stefan
    Schmutz, Guenther
    Jessen, Heiko
    Weitner, Lutwin
    Mutz, Antonius
    Schranz, Dietmar
    Rockstroh, Juergen K.
    JOURNAL OF INFECTION, 2006, 53 (01) : 36 - 42
  • [4] Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Piketty, C
    Van Huyen, LPD
    Bloch, F
    Belec, L
    Bruneval, P
    Weiss, L
    Jian, R
    Kazatchkine, MD
    AIDS, 2001, 15 (16) : 2149 - 2155
  • [5] Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Van Huyen, JPD
    Piketty, C
    Bloch, F
    Pialoux, G
    Belec, L
    Petite, JP
    Weiss, L
    Kazatchkine, M
    AIDS, 2000, 14 (07) : 839 - 844
  • [6] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [7] Histological and virological long-term outcome in patients treated with interferon-α2b and ribavirin for chronic hepatitis C
    Schvarcz, R
    Glaumann, H
    Reichard, O
    Weiland, O
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) : 237 - 242
  • [8] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [9] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [10] Interferon-α-2b and ribavirin for retreatment of chronic hepatitis C
    Dettmer, RM
    Reinus, JF
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    Isaacson, MP
    Spinnell, M
    Meyer, D
    Sarabanchong, V
    Zhang, YT
    Garcia-Carrasquillo, RJ
    Markowitz, DD
    Magun, AM
    Worman, HJ
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 758 - 763
12345